NVS

Novartis AG

100,80
0,15 (0,15%)
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Novartis AG NVS NYSE Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,15 0,15% 100,80 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
100,35 99,68 101,03 100,93 100,65
mais cotações »

Notícias Recentes

Data Hora Fonte Título
08/06/202308:00PRNUSKAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO..
08/06/202303:03DJNNovartis's Sandoz Sets Out Growth Plan Following Proposed..
02/06/202309:49DJNNovartis Says Kisqali Significantly Lowered the Risk of..
01/06/202303:15DJNNovartis's Sandoz to Move to New Basel Headquarters After..
25/05/202303:00DJNNovartis's Sandoz Gets European Authorization for Biosimilar..
15/05/202303:08DJNNovartis Approves Sandoz's New Board Ahead of Spinoff
10/05/202305:33DJNEvotec Shares Jump After Sandoz Partnership Agreement
10/05/202303:07DJNNovartis Unit Sandoz Enters Partnership With Evotec..
26/04/202307:15DJNNovartis's Blood-Disorder Drug Trial Meets Primary Endpoint
25/04/202303:03DJNNovartis 1Q Profit, Sales Beat Expectations; Raises 2023..
27/03/202312:28DJNNovartis Up Over 7%, on Pace for Largest Percent Increase..
27/03/202304:57DJNNovartis Shares Gain After Positive Breast-Cancer Trial..
27/03/202302:56DJNNovartis Gets Positive Result From Breast-Cancer Drug Trial
22/03/202307:36DJNNovartis Drops Plan for Major Trial in UK, FT Reports
17/03/202320:15DJNSangamo Shares Down 8% After Hours as Novartis, Biogen End..
09/03/202310:46DJNNovartis's Sandoz Invests at Least $400 Million in Slovenian..
06/03/202309:00GLOBEVoyager Therapeutics to Receive $25 Million Payment for..
20/02/202303:58DJNNovartis Names Sandoz Board Chairman Ahead of Spinoff
01/02/202319:34DJNADRs End Mostly Higher, Airbus and Novartis Trade Actively
01/02/202314:24DJNTrending: Novartis's 4Q Net Profit Declines on Poor Drug..
01/02/202304:00DJNNovartis Lifts Dividend Despite 4Q Sales, Profit Decline
29/12/202216:38DJNTrending: Novartis to Pay $245 Million in Antitrust..
29/12/202208:31DJNNovartis to Pay $245 Million in Settlement Over Antitrust..
14/12/202209:28DJNHarrow Health to Buy U.S. Rights to Novartis Drugs For Up to..
13/12/202204:01DJNEU Approves Novartis's Prostate Cancer Treatment
12/12/202208:54DJNClovis Oncology Shares Fall Premarket After Bankruptcy..
09/12/202215:15DJNErasca Shares Drop 30% After Pricing of $100 Million..
08/12/202204:12DJNNovartis Phase 3 Trial for Hemoglobinuria Drug Iptacopan Met..
05/12/202220:38DJNADRs End Lower, Vodafone and Glencore Trade Actively
05/12/202203:57DJNNovartis Prostate Cancer Drug Trial Meets Primary Endpoint
16/11/202212:17DJNNovartis Mulls Sale of Opthalmology, Respiratory Businesses,..
25/10/202203:00DJNNovartis 3Q Sales, Earnings Miss Expectations, but Backs..
24/10/202202:59DJNNovartis Hemoglobinuria Trial Meets Two Primary Endpoints
14/10/202205:52TRMNThe U.S. Supreme Court Rejects Novartis’ (NYSE:NVS) Bid to..
07/10/202217:07TRMNNovartis price target lowered to CHF 70 from CHF 75 at..
30/09/202206:02TRMNNovartis (NYSE: NVS) Wins Reprieve From U.S. Supreme Court..
21/09/202203:07DJNNovartis to Petition US Supreme Court on Gilenya Patent
19/09/202203:06DJNNovartis Says Sandoz Biosimilar Met Primary Endpoints in..
15/09/202203:16DJNNovartis Says Authorities Investigating a Patent Assertion
14/09/202207:15TRMNNovartis (NYSE: NVS) Scores a Win As Lawsuit is Thrown Out
12/09/202207:19TRMNNovartis’ (NYSE:NVS) Consentyx Improves Symptoms of Skin..
25/08/202211:31DJNTrending: Novartis Moves to Spin off Sandoz
25/08/202202:49DJNNovartis to Spin Off, List Sandoz Business
15/08/202203:05DJNNovartis Phase 3 Canopy-A Trial Didn't Meet Primary Endpoint
12/08/202206:35DJNNovartis Says Two Children Treated With Gene-Therapy..
08/08/202209:45IHNWThe Power of Science to Stop a Killer
19/07/202203:22DJNNovartis 2Q Earnings, Sales Fell
01/07/202204:34TRMNEverything You Need to Know If You’re Worried About..
29/06/202208:39TRMNNovartis Leans on Job Cuts to Boost Bottom line
23/06/202203:31DJNNovartis to Boost Development of Anti-Malaria,..
Seu Histórico Recente
NYSE
NVS
Novartis
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Faça o login em ADVFN
Registrar agora

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

Support: (11) 4950 5808 | suporte@advfn.com.br

V: D: 20230610 13:37:52